84 related articles for article (PubMed ID: 18502415)
1. GSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286.
Yeste-Velasco M; Folch J; Jiménez A; Rimbau V; Pallàs M; Camins A
Eur J Pharmacol; 2008 Jul; 588(2-3):239-43. PubMed ID: 18502415
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons.
Pizarro JG; Yeste-Velasco M; Rimbau V; Casadesús G; Smith MA; Pallàs M; Folch J; Camins A
Int J Dev Neurosci; 2008; 26(3-4):269-76. PubMed ID: 18342477
[TBL] [Abstract][Full Text] [Related]
3. A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.
Pizarro JG; Folch J; Esparza JL; Jordan J; Pallàs M; Camins A
J Cell Mol Med; 2009 Sep; 13(9B):3906-17. PubMed ID: 18624766
[TBL] [Abstract][Full Text] [Related]
4. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium.
Jordà EG; Verdaguer E; Canudas AM; Jiménez A; Garcia de Arriba S; Allgaier C; Pallàs M; Camins A
Neuroscience; 2005; 134(3):1001-11. PubMed ID: 15979805
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 inhibitors augment TRAIL-induced apoptotic death in human hepatoma cells.
Beurel E; Blivet-Van Eggelpoël MJ; Kornprobst M; Moritz S; Delelo R; Paye F; Housset C; Desbois-Mouthon C
Biochem Pharmacol; 2009 Jan; 77(1):54-65. PubMed ID: 18938143
[TBL] [Abstract][Full Text] [Related]
6. A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium.
Linseman DA; Cornejo BJ; Le SS; Meintzer MK; Laessig TA; Bouchard RJ; Heidenreich KA
J Neurochem; 2003 Jun; 85(6):1488-99. PubMed ID: 12787068
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GSK3beta is a common event in neuroprotection by different survival factors.
Chin PC; Majdzadeh N; D'Mello SR
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):193-201. PubMed ID: 15950778
[TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity.
Facci L; Stevens DA; Skaper SD
Neuroreport; 2003 Aug; 14(11):1467-70. PubMed ID: 12960765
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.
Kaga S; Zhan L; Altaf E; Maulik N
J Mol Cell Cardiol; 2006 Jan; 40(1):138-47. PubMed ID: 16288908
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress and trophic factor withdrawal activate distinct signaling cascades that induce glycogen synthase kinase-3 beta and a caspase-9-dependent apoptosis in cerebellar granule neurons.
Brewster JL; Linseman DA; Bouchard RJ; Loucks FA; Precht TA; Esch EA; Heidenreich KA
Mol Cell Neurosci; 2006 Jul; 32(3):242-53. PubMed ID: 16765055
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of lithium and valproic acid on trophic factor deprivation-induced glycogen synthase kinase-3 activation, c-Jun expression and neuronal cell death.
Jin N; Kovács AD; Sui Z; Dewhurst S; Maggirwar SB
Neuropharmacology; 2005 Mar; 48(4):576-83. PubMed ID: 15755485
[TBL] [Abstract][Full Text] [Related]
13. Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model.
Crespo-Biel N; Camins A; Gutiérrez-Cuesta J; Melchiorri D; Nicoletti F; Pallàs M; Canudas AM
Hippocampus; 2010 Aug; 20(8):962-70. PubMed ID: 19714564
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of atypical D1 receptor agonist SKF83959 are mediated via D1 receptor-dependent inhibition of glycogen synthase kinase-3 beta and a receptor-independent anti-oxidative action.
Yu Y; Wang JR; Sun PH; Guo Y; Zhang ZJ; Jin GZ; Zhen X
J Neurochem; 2008 Feb; 104(4):946-56. PubMed ID: 18005341
[TBL] [Abstract][Full Text] [Related]
15. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity.
Culbert AA; Brown MJ; Frame S; Hagen T; Cross DA; Bax B; Reith AD
FEBS Lett; 2001 Nov; 507(3):288-94. PubMed ID: 11696357
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
17. Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
Leng Y; Liang MH; Ren M; Marinova Z; Leeds P; Chuang DM
J Neurosci; 2008 Mar; 28(10):2576-88. PubMed ID: 18322101
[TBL] [Abstract][Full Text] [Related]
18. Recruitment of active glycogen synthase kinase-3 into neuronal lipid rafts.
Sui Z; Kovács AD; Maggirwar SB
Biochem Biophys Res Commun; 2006 Jul; 345(4):1643-8. PubMed ID: 16735023
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of bone formation in the expanding premaxillary suture with a GSK-3β inhibitor.
Jiang Y; Liu HX; Guo JJ; Tang GH; Qian YF
Oral Dis; 2013 Jan; 19(1):73-9. PubMed ID: 22776263
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.
Menon B; Johnson JN; Ross RS; Singh M; Singh K
J Mol Cell Cardiol; 2007 Mar; 42(3):653-61. PubMed ID: 17292911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
